Dataset from A Multicenter, Double Blind, Randomized, Placebo Controlled, Parallel Group Study to Investigate the Efficacy and Safety of Lacosamide as Adjunctive Therapy in Subjects With Epilepsy ≥4 Years to <17 Years of Age With Partial Onset Seizures

Study to evaluate the efficacy of Lacosamide (LCM) administered in addition to 1 to ≤3 other
Anti-Epileptic Drugs in subjects with epilepsy ≥4 years to <17 years of age who currently
have uncontrolled partial onset seizures.